Pillstats
Capsule

Fluoxetine

Fluoxetine Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AB03
RxCUI (US)4493
US makers1 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.010$0.019$0.029$0.038Dec 2025Mar 2026Jul 2026
$0.032
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

49K99K148K198K2025 Q42026 Q1
172K
Rx · 2026 Q1
8.3M
Units dispensed
2
Quarters · since 2025 Q4

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown10SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.